Skip to main content
Steven Nathan, MD, Pulmonology, Falls Church, VA

StevenDNathanMD

Pulmonology Falls Church, VA

Professor, University of Virginia

Dr. Nathan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Nathan's full profile

Already have an account?

  • Office

    3300 Gallows Rd
    Heart and Lung Transplant
    Falls Church, VA 22042
    Phone+1 703-776-2986
    Fax+1 703-776-3515

Summary

  • Steven D. Nathan, MD, FCCP, is the medical director of Inova's Advanced Lung Disease Program and Lung Transplant Program at Inova Heart and Vascular Institute - Inova Fairfax Medical Campus. He also is a professor at the University of Virginia.

    Dr. Nathan is board certified in pulmonary diseases, critical care medicine and internal medicine. The author of more than 500 publications, Dr. Nathan is internationally recognized for his expertise in advanced lung diseases. He is co-editor of two books on idiopathic pulmonary fibrosis that provide pulmonologists and other healthcare workers with an up-to-date review of the background and advances in the field: Idiopathic Pulmonary Fibrosis and Guide to Clinical Management of Idiopathic Pulmonary Fibrosis. He also has written original research manuscripts, abstracts, reviews and book chapters. Dr. Nathan is a reviewer for multiple journals and is on the editorial board for the journal, Thorax. He has served on multiple committees, including U.S. Food and Drug Administration advisory boards as well as steering committees for clinical trials in IPF and pulmonary hypertension, where he has also served as chair.
    Dr. Nathan is a member of several professional medical associations, including the American Thoracic Society, the American College of Chest Physicians, and the International Society for Heart and Lung Transplantation. He has delivered talks and been chairperson of numerous sessions at many national and international conferences.

Education & Training

  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1988 - 1992
  • Zucker School of Medicine at Hofstra/Northwell
    Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1985 - 1988
  • University of the Witwatersrand
    University of the WitwatersrandClass of 1981

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1988 - Present
  • VA State Medical License
    VA State Medical License 1994 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • First Patient Enrolled in TETON 2 Phase 3 Trial of Tyvaso for IPF
    First Patient Enrolled in TETON 2 Phase 3 Trial of Tyvaso for IPFOctober 14th, 2022
  • United Therapeutics Announces First Patient Enrolled in Phase 3 TETON 2 Study of Tyvaso in Patients with Idiopathic Pulmonary Fibrosis
    United Therapeutics Announces First Patient Enrolled in Phase 3 TETON 2 Study of Tyvaso in Patients with Idiopathic Pulmonary FibrosisOctober 11th, 2022
  • Bellerophon Cleared to ‘Downsize’ Patients in PF Study of INOpulse
    Bellerophon Cleared to ‘Downsize’ Patients in PF Study of INOpulseSeptember 30th, 2022
  • Join now to see all